Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
Related LJPC
Here's What Makes La Jolla Pharma A 2017 Top Pick At Chardan
16 Stocks Moving In Monday's Pre-Market Session
La Jolla Pharmaceutical misses by $0.24, misses on revenue (Seeking Alpha)
Related DRII
The Grass Is Always Greener: Why Companies Switch From Private To Public And Vice Versa
Why Is Apollo Global Going On A 2016 Shopping Spree?

Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma is set to $25. La Jolla Pharma's shares closed at $9.40 on Friday.

Imperial Capital initiated coverage on shares of Diamond Resorts (NYSE: DRII) with a Outperform rating. The target price for Diamond Resorts is set to $34. Diamond Resorts' shares closed at $24.95 on Friday.

Latest Ratings for LJPC

Jun 2016SunTrust Robinson HumphreyInitiates Coverage onBuy
Feb 2016Cowen & Co.Initiates Coverage onOutperform
Apr 2015OppenheimerInitiates Coverage onOutperform

View More Analyst Ratings for LJPC
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (LJPC + DRII)

View Comments and Join the Discussion!